Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2013 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 20 stocks in 2013 Q3, with total market value around $3.50B.
Baupost Group's top five holdings in 2013 Q3: Micron Technology, Inc.(MU) 31.95%, THERAVANCE INC 21.62%, VIASAT INC(VSAT) 20.01%, BP PLC-SPONS ADR(BP) 6.72%, IDENIX PHARMACEUTICALS INC 4.40%.
- Portfolio Value
- $3.50B
- Current Holdings
- 20 stocks
- New / Increased
- 1 / 4
- Reduced / Exited
- 4 / 5
Current Holdings
| 1 | Micron Technology, Inc.MU | 1.12 | 31.95% | 64.00 +54.22% | $17.47 | $971.00 +5458.42% | $15.43 | +22.50 | 0.50 | +$61.16B+6191.47% | Increased |
| 2 | THERAVANCE INCCUSIP 88338T104 | 0.76 | 21.62% | 18.51 +11.92% | $40.87 | - | $38.78 | +1.97 | 0.50 | +$0.04B+5.39% | Increased |
| 3 | VIASAT INCVSAT | 0.70 | 20.01% | 11.00 - | $63.64 | - | $71.46 | 0.00 | 0.50 | -$0.09B-10.94% | Held |
| 4 | BP PLC-SPONS ADRBP | 0.24 | 6.72% | 5.60 -69.90% | $42.03 | - | $41.74 | -13.00 | 0.50 | +$0.00B+0.69% | Reduced |
| 5 | IDENIX PHARMACEUTICALS INCCUSIP 45166R204 | 0.15 | 4.40% | 29.67 +10.83% | $5.19 | - | $3.76 | +2.90 | 0.50 | +$0.04B+37.87% | Increased |
| 6 | ROVI CORP COMCUSIP 779376102 | 0.12 | 3.38% | 6.16 - | $19.17 | - | $22.84 | 0.00 | 0.50 | -$0.02B-16.07% | Held |
| 7 | Oracle CorporationORCL | 0.08 | 2.26% | 2.39 - | $33.17 | $299.00 +801.42% | $30.71 | 0.00 | 0.50 | +$0.64B+873.63% | Held |
| 8 | CITIGROUP INCCUSIP 172967226 | 0.07 | 2.01% | 94.25 - | $0.75 | - | $0.79 | 0.00 | 0.50 | -$0.00B-4.83% | Held |
| 9 | CHIPMOS TECH BERMUDA LTDCUSIP G2110R114 | 0.06 | 1.69% | 3.28 +18.81% | $17.98 | - | $19.13 | +0.52 | 0.50 | -$0.00B-6.03% | Increased |
| 10 | NOVAGOLD RES INCCUSIP 66987E206 | 0.05 | 1.44% | 21.69 - | $2.32 | - | $2.11 | 0.00 | 0.50 | +$0.00B+9.95% | Held |
| 11 | SYNERON MEDICAL LTDCUSIP M87245102 | 0.03 | 0.99% | 4.00 - | $8.62 | - | $8.70 | 0.00 | 0.50 | -$0.00B-0.92% | Held |
| 12 | PBF ENERGY INCCUSIP 69318G106 | 0.02 | 0.61% | 0.96 | $22.45 | - | $22.45 | +0.96 | 0.25 | $0.00B0.00% | New |
| 13 | ALLIANCE ONE INTL INCCUSIP 018772103 | 0.02 | 0.53% | 6.38 -16.77% | $2.91 | - | $3.80 | -1.29 | 0.50 | -$0.01B-23.42% | Reduced |
| 14 | MICRON TECHNOLOGY INC DEBT 1.875% 6/0CUSIP 595112AK9可转换债券 | 0.02 | 0.52% | 11.37 - | $1.60 | - | $1.34 | 0.00 | 0.50 | +$0.00B+19.50% | Held |
| 15 | CENTRAL PAC FINL CORPCUSIP 154760409 | 0.01 | 0.39% | 0.78 -47.73% | $17.70 | - | $18.00 | -0.71 | 0.50 | -$0.00B-1.67% | Reduced |
| 16 | ENZON PHARMACEUTICALS INCCUSIP 293904108 | 0.01 | 0.37% | 7.69 - | $1.68 | - | $2.00 | 0.00 | 0.50 | -$0.00B-16.00% | Held |
| 17 | AMERICAN INTL GROUP INCCUSIP 026874156 | 0.01 | 0.36% | 0.66 - | $18.95 | - | $18.24 | 0.00 | 0.50 | +$0.00B+3.89% | Held |
| 18 | NOVACOPPER INCCUSIP 66988K102 | 0.01 | 0.27% | 5.01 - | $1.89 | - | $1.75 | 0.00 | 0.50 | +$0.00B+8.01% | Held |
| 19 | ITURAN LOCATION AND CONTROLCUSIP M6158M104 | 0.01 | 0.25% | 0.48 -54.12% | $18.45 | - | $16.87 | -0.56 | 0.50 | +$0.00B+9.36% | Reduced |
| 20 | AVEO PHARMACEUTICALS INCCUSIP 053588109 | 0.01 | 0.23% | 3.83 - | $2.06 | - | $2.50 | 0.00 | 0.50 | -$0.00B-17.60% | Held |
Showing 1-20 of 20
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2013 Q3.
| 1 | AMERICAN INTERNATIONAL GROUPAIG | 10.12 | 0.25 | $44.70 | $48.63 | +$0.04B+8.79% |
| 2 | THERAVANCE INCCUSIP 88338TAA2 | 51.00 | 0.25 | $1.56 | $1.56 | $0.00B0.00% |
| 3 | YAMANA GOLD INCCUSIP 98462Y100 | 3.26 | 0.25 | $9.51 | $9.51 | $0.00B0.00% |
| 4 | KINROSS GOLD CORPCUSIP 496902404 | 2.10 | 0.25 | $5.10 | $5.10 | $0.00B0.00% |
| 5 | PRETIUM RES INCCUSIP 74139C102 | 0.16 | 0.25 | $6.63 | $6.63 | $0.00B0.00% |
Showing 1-5 of 5
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.